(Reuters) - U.S. drug regulators approved Eli Lilly's Cialis drug to treat enlargement of the prostate on Thursday, expanding use of the blockbuster impotence medicine. The Food and Drug ...

announced today that the European Commission has approved Cialis 5 mg for once daily use for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH). Cialis was approved for ...

INDIANAPOLIS (AP) — A European committee has endorsed the use of Eli Lilly and Co.’s erectile dysfunction drug Cialis to treat symptoms tied to an enlarged prostate. Reid Rasner touts 'Trumpianism' in ...

The FDA has approved tadalafil (Cialis) for the once daily use as a treatment for benign prostatic hyperplasia (BPH). The agency also approved the medication for once daily use as a treatment for men ...

Paris, January 21, 2025. Opella, Sanofi’s Consumer Healthcare business, announced that the US Food and Drug Administration (FDA) has lifted a clinical hold on its planned actual use trial (AUT) to ...

Currently only available with a prescription, Cialis is a tablet taken to treat erectile dysfunction (ED), the signs and symptoms of benign prostatic hyperplasia (BPH), and both ED and the signs and ...

The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for Tadalafil Mylan (Generics UK Ltd) for the treatment of men with ...